Furthermore, the EC_shNogo-B supernatant-enhanced proliferation of cancer cells was abolished by either a TGF-β neutralizing antibody or TGF-β receptor inhibitor, suggesting an essential role for TGF-β in endothelial Nogo-B-mediated suppression of cancer growth (Figure 5F,G). Here, TGFB1 is linked to cancer.